Figure 2. Adjusteda logistic regression model of association between race and nodal pathologic complete response among patients with clinically node positive breast cancer after neoadjuvant chemotherapy, stratified by breast cancer subtype.
a Adjusted for age, place of residence, insurance, cancer care facility type, Charlson Comorbidity Index, histology, grade, receipt of endocrine therapy for hormone receptor-positive subtypes, and receipt of immunotherapy for HER2+ subtypes